Suppr超能文献

基于 miRNA 的条件性反义寡核苷酸

Conditional Antisense Oligonucleotides Triggered by miRNA.

机构信息

Wallace H. Coulter Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, Georgia 30332, United States.

Department of Chemistry, Emory University, Atlanta, Georgia 30322, United States.

出版信息

ACS Chem Biol. 2021 Nov 19;16(11):2255-2267. doi: 10.1021/acschembio.1c00387. Epub 2021 Oct 19.

Abstract

Antisense oligonucleotides (ASOs) are single-stranded short nucleic acids that silence the expression of target mRNAs and show increasing therapeutic potential. Since ASOs are internalized by many cell types, both normal and diseased cells, gene silencing in unwanted cells is a significant challenge for their therapeutic use. To address this challenge, we created conditional ASOs that become active only upon detecting transcripts unique to the target cell. As a proof-of-concept, we modified an HIF1α ASO (EZN2968) to generate miRNA-specific conditional ASOs, which can inhibit HIF1α in the presence of a hepatocyte-specific miRNA, miR-122, via a toehold exchange reaction. We characterized a library of nucleic acids, testing how the conformation, thermostability, and chemical composition of the conditional ASO impact the specificity and efficacy in response to miR-122 as a trigger signal. Optimally designed conditional ASOs demonstrated knockdown of HIF1α in cells transfected with exogenous miR-122 and in hepatocytes expressing endogenous miR-122. We confirmed that conditional ASO activity was mediated by toehold exchange between miR-122 and the conditional ASO duplex, and the magnitude of the knockdown depended on the toehold length and miR-122 levels. Using the same concept, we further generated another conditional ASO that can be triggered by miR-21. Our results suggest that conditional ASOs can be custom-designed with any miRNA to control ASO activation in targeted cells while reducing unwanted effects in nontargeted cells.

摘要

反义寡核苷酸(ASO)是单链短核酸,可沉默靶 mRNA 的表达,并显示出越来越大的治疗潜力。由于 ASO 被许多细胞类型(包括正常细胞和病变细胞)内化,因此在不需要的细胞中实现基因沉默是其治疗用途的一个重大挑战。为了解决这一挑战,我们创建了条件性 ASO,这些 ASO 只有在检测到靶细胞特有的转录本时才会变得活跃。作为概念验证,我们对 HIF1α ASO(EZN2968)进行了修饰,以生成 miRNA 特异性条件性 ASO,这些 ASO 可以通过引发置换反应,在存在肝细胞特异性 miRNA miR-122 的情况下抑制 HIF1α。我们对一组核酸进行了表征,测试了条件性 ASO 的构象、热稳定性和化学组成如何影响其对 miR-122 作为触发信号的特异性和疗效。经过优化设计的条件性 ASO 在外源转染 miR-122 的细胞和表达内源性 miR-122 的肝细胞中均能有效抑制 HIF1α。我们证实,条件性 ASO 的活性是通过 miR-122 与条件性 ASO 双链体之间的引发置换反应介导的,敲低的幅度取决于引发物的长度和 miR-122 的水平。基于相同的概念,我们进一步生成了另一种可以被 miR-21 触发的条件性 ASO。我们的结果表明,可以根据任何 miRNA 定制设计条件性 ASO,以控制靶向细胞中 ASO 的激活,同时减少对非靶向细胞的不良影响。

相似文献

1
Conditional Antisense Oligonucleotides Triggered by miRNA.基于 miRNA 的条件性反义寡核苷酸
ACS Chem Biol. 2021 Nov 19;16(11):2255-2267. doi: 10.1021/acschembio.1c00387. Epub 2021 Oct 19.
8
Potent inhibition of microRNA in vivo without degradation.在体内对微小RNA进行有效抑制而不发生降解。
Nucleic Acids Res. 2009 Jan;37(1):70-7. doi: 10.1093/nar/gkn904. Epub 2008 Nov 16.
10
Improved targeting of miRNA with antisense oligonucleotides.利用反义寡核苷酸改善对微小RNA的靶向作用。
Nucleic Acids Res. 2006 May 11;34(8):2294-304. doi: 10.1093/nar/gkl183. Print 2006.

本文引用的文献

1
Smart Nucleic Acids as Future Therapeutics.智能核酸:未来的治疗策略。
Trends Biotechnol. 2021 Dec;39(12):1289-1307. doi: 10.1016/j.tibtech.2021.03.007. Epub 2021 May 10.
5
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease.患者定制型寡核苷酸疗法治疗罕见遗传病。
N Engl J Med. 2019 Oct 24;381(17):1644-1652. doi: 10.1056/NEJMoa1813279. Epub 2019 Oct 9.
7
Therapeutic Antisense Oligonucleotides Are Coming of Age.治疗性反义寡核苷酸渐趋成熟。
Annu Rev Med. 2019 Jan 27;70:307-321. doi: 10.1146/annurev-med-041217-010829.
9
Improving siRNA Delivery In Vivo Through Lipid Conjugation.通过脂质缀合改善体内 siRNA 递送。
Nucleic Acid Ther. 2018 Jun;28(3):128-136. doi: 10.1089/nat.2018.0725. Epub 2018 May 10.
10
Recent preclinical and clinical advances in oligonucleotide conjugates.寡核苷酸缀合物的最新临床前和临床进展。
Expert Opin Drug Deliv. 2018 Jun;15(6):629-640. doi: 10.1080/17425247.2018.1473375. Epub 2018 May 16.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验